Moisture, mold can be controlled with DampRid
MEMPHIS, Tenn. Water damage can lead to mold and mildew growth, but a line of environmentally friendly calcium chloride moisture absorbers can eliminate musty odors and the dampness that cause such damage.
DampRid offers a line of moisture absorber products that control moisture to eliminate the dampness that enables mold to grow. DampRid moisture control expert Darin Galka recommended that home owners always control the existing moisture level in their homes by placing DampRid, a line of environmentally friendly calcium chloride moisture absorbers, in such key areas as bathrooms, kitchens, laundry rooms, basements and garages.
“Water damage quickly leads to the growth of mold and mildew, which grow in the presence of humidity,” Galka said. “Spores can begin growing and reproducing within 48 hours.”
Season 13 of ‘The Simpsons’ arrives on Blu-ray, DVD this summer
LOS ANGELES Twentieth Century Fox Home Entertainment is bringing the residents of Springfield to Blu-ray and DVD this August.
The complete 13th season of television’s longest running comedy — “The Simpsons” — will arrive Aug. 24. The season features 22 episodes including two noteworthy standouts: the Simpsons’ trip to Brazil in “Blame It On Lisa” and Homer’s foray into medicinal marijuana in “Weekend at Burnsie’s.” Once again, a talented line-up of guest stars lend their voices including Ben Stiller, Reese Witherspoon, Richard Gere, Pierce Brosnan, Matthew Perry, R.E.M. and Paul Newman.
“The Simpsons” the complete 13th season is packed with special features including deleted scenes, audio commentaries on every episode, featurettes, storyboards, animatics, easter eggs and much more. The Blu-ray release also includes specially created menus with additional animation that does not appear on the DVD. The set comes in collectible packaging modeled after Springfield’s “special” child, Ralph Wiggum. The Blu-ray and DVD will be available for the suggested retail price of $59.99 and $49.98, respectively.
Decision Resources: Atrial fibrillation treatments will expand market size to $7 billion
WALTHAM, Mass. Launch and use of new heart drugs will drive the market for drugs to treat atrial fibrillation and increase its size to nearly $7 billion in less than a decade, according to a new report from market analysis firm Decision Resources.
The report found that new drugs from Boehringer Ingelheim, Sanofi-Aventis and partnerships between Bayer and Johnson & Johnson and Pfizer and Bristol-Myers Squibb –– specifically anticoagulant and antiarrhythmic drugs –– will drive most of the atrial fibrillation drug market in developed countries and increase it more than eight-fold, from $843 million in 2009 to $6.8 billion in 2019.
The drugs cited include Boehringer Ingelheim’s Pradaxa (dabigatran etexilate), Sanofi-Aventis’ Multaq (dronedarone), apixan, by Bristol and Pfizer, and Xarelto (rivaroxaban), by Bayer and J&J. These drugs are expected to drive three-quarters of the market in the United States, United Kingdom, France, Italy, Spain, Germany and Japan.
The report found that while Multaq would face challenges due to competition from another Sanofi drug, Cordarone (amiodarone), which also is available as a generic, it would likely have sales of more than $650 million in 2019.